Report cover image

Therapeutic Drug Monitoring Market Report and Forecast 2025-2034

Publisher Expert Market Research
Published Jul 28, 2025
Length 350 Pages
SKU # EMAR20319966

Description

The global therapeutic drug monitoring market size was valued at USD 2.20 Billion  in 2024 , driven by the emphasis on evaluating a drugs’ efficacy in a patient and precision medicine across the globe. The market is expected to grow at a CAGR of 9.10% during the forecast period of 2025-2034, with the values likely to rise USD 5.26 Billion by 2034 .

Therapeutic Drug Monitoring: Introduction

Therapeutic drug monitoring is the periodic measurement of several drugs in the bloodstream. It is an evaluation to ensure that a patient is adhering to the prescribed dosage. It is also used to gauge the effectiveness of the medications.

Therapeutic drug monitoring is used to optimize the dosages for people who are taking certain medicines, which can be hard to dose due to potential side effects. Such medicines may range from antibiotics, heart drugs, anti-seizure drugs, and drugs to treat autoimmune diseases. It is also known as medicine levels blood test or therapeutic drug levels test.

Global Therapeutic Drug Monitoring Market Analysis

Therapeutic drug monitoring plays a critical role in clinical practice. Monitoring drug levels in individual patients allows for patient-specific dose optimisation. Therefore, there has been a notable upswing in the therapeutic drug monitoring market demand, particularly with precision medicine gaining prominence in today’s healthcare system.

Conventional therapeutic drug monitoring techniques are time-consuming and labour-intensive. They require large sample volumes, along with a substantial number of organic solvents. In some cases, samples must be sent to central laboratories for analysis as well, potentially causing a delay in getting the required results. In this regard, Raman spectroscopy has emerged as a promising technique that offers label-free and non-invasive characteristics that also facilitate smooth, rapid, and precise analysis.

Furthermore, UCL researchers have also developed a new drug-monitoring tool called ChromaDose that calculates the efficacy of cancer medicine in a patient’s bloodstream. It is aimed at reducing heart issues and other side effects experienced by kids receiving chemotherapy. This point-of-care tool can be made available in hospitals by 2025. In addition, there has been ongoing research on dual-colour bioluminescent sensor proteins for therapeutic drug monitoring of antitumor antibodies. As research and development continue to progress, therapeutic drug monitoring market value will increase in the forecast period.

Global Therapeutic Drug Monitoring Market Segmentation

Global Therapeutic Drug Monitoring Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type
  • Consumables
  • Devices
  
  • Immunoassay Analyzers

    •   
  • Chromatography and MS Detectors

    •   
  • Clinical Chemistry Analyzers

    •   
  • Others

    • Market Market Breakup by Type
    • Immunoassays
    • Proteomic Technologies
    Market Breakup by Drug Class
    • Antiepileptic
    • Antiarrhythmic
    • Immunosuppressants
    • Antibiotic Drugs
    • Bronchodilator Drugs
    • Psychoactive Drugs
    • Others
    Market Market Breakup by End User
    • Hospitals
    • Commercial and Private Laboratories
    • Others
    Market Market Breakup by Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
    Global Therapeutic Drug Monitoring Market Overview

    With the prominence of precision medicine, researchers have turned towards therapeutic drug monitoring for treating diseases where accurate measurement of drugs plays a vital role in the treatment. For instance, in diseases like inflammatory bowel disease and paediatric cystic fibrosis treatment, therapeutic drug monitoring is being used to enhance treatment outcomes. This indicates the certainty of therapeutic drug monitoring market growth in upcoming years.

    Considering the growing population, developing infrastructure, and increased technical advancements in the Asia Pacific region, the market for therapeutic drug monitoring is expected to observe a steep growth. Increased awareness regarding diagnostics is another factor fuelling the growth, in contrast to the historical period, when the United States led the therapeutic drug monitoring market share. This can be attributed to the presence of major healthcare giants in the area, committed to work on new innovations, envisioned at improving patient treatment and overall experience.

    Global Therapeutic Drug Monitoring Market: Competitor Landscape

    The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
    • Abbott
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche
    • Siemens Healthineers AG
    • Danaher Corporation
    • Bio-Rad Laboratories
    • Biomérieux SA
    • Theradiag
    • Grifols S.A.
    • Exagen Inc.
    • Ark Diagnostics, Inc.
    • R-Biopharm A
    • Apdia Group
    • Biotez Berlin Buch GmbH
    • Eagle Biosciences, Inc.
    *Please Note:* The report will take 5 business days to complete, after order confirmation.

    Table of Contents

    350 Pages
    1 Preface
    1.1 Objectives of the Study
    1.2 Key Assumptions
    1.3 Report Coverage – Key Segmentation and Scope
    1.4 Research Methodology
    2 Executive Summary
    3 Global Therapeutic Drug Monitoring Market Overview
    3.1 Global Therapeutic Drug Monitoring Market Historical Value (2018-2024)
    3.2 Global Therapeutic Drug Monitoring Market Forecast Value (2025-2034)
    4 Global Therapeutic Drug Monitoring Market Landscape
    4.1 Global Therapeutic Drug Monitoring Developers Landscape
    4.1.1 Analysis by Year of Establishment
    4.1.2 Analysis by Company Size
    4.1.3 Analysis by Region
    4.2 Global Therapeutic Drug Monitoring Product Landscape
    4.2.1 Analysis by Product
    4.2.2 Analysis by Type
    4.2.3 Analysis by Drug Class
    5 Global Therapeutic Drug Monitoring Market Dynamics
    5.1 Market Drivers and Constraints
    5.2 SWOT Analysis
    5.3 Porter’s Five Forces Model
    5.4 Key Demand Indicators
    5.5 Key Price Indicators
    5.6 Industry Events, Initiatives, and Trends
    5.7 Value Chain Analysis
    6 Global Therapeutic Drug Monitoring Market Segmentation
    6.1 Global Therapeutic Drug Monitoring Market by Product Type
    6.1.1 Market Overview
    6.1.2 Consumables
    6.1.3 Devices
    6.1.3.1 Immunoassay Analyzers
    6.1.3.2 Chromatography and Ms Detectors
    6.1.3.3 Clinical Chemistry Analyzers
    6.1.3.4 Others
    6.2 Global Therapeutic Drug Monitoring Market by Type
    6.2.1 Market Overview
    6.2.2 Immunoassays
    6.2.3 Proteomic Technologies
    6.3 Global Therapeutic Drug Monitoring Market by Drug Class
    6.3.1 Market Overview
    6.3.2 Antiepileptic
    6.3.3 Antiarrhythmic
    6.3.4 Immunosuppressants
    6.3.5 Antibiotic Drugs
    6.3.6 Bronchodilator Drugs
    6.3.7 Psychoactive Drugs
    6.3.8 Others
    6.4 Global Therapeutic Drug Monitoring Market by End User
    6.4.1 Market Overview
    6.4.2 Hospitals
    6.4.3 Commercial and Private Laboratories
    6.4.4 Others
    6.5 Global Therapeutic Drug Monitoring Market by Region
    6.5.1 Market Overview
    6.5.2 North America
    6.5.3 Europe
    6.5.4 Asia Pacific
    6.5.5 Latin America
    6.5.6 Middle East and Africa
    7 North America Therapeutic Drug Monitoring Market
    7.1 Market Share by Country
    7.2 United States of America
    7.3 Canada
    8 Europe Therapeutic Drug Monitoring Market
    8.1 Market Share by Country
    8.2 United Kingdom
    8.3 Germany
    8.4 France
    8.5 Italy
    8.6 Others
    9 Asia Pacific Therapeutic Drug Monitoring Market
    9.1 Market Share by Country
    9.2 China
    9.3 Japan
    9.4 India
    9.5 ASEAN
    9.6 Australia
    9.7 Others
    10 Latin America Therapeutic Drug Monitoring Market
    10.1 Market Share by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Mexico
    10.5 Others
    11 Middle East and Africa Therapeutic Drug Monitoring Market
    11.1 Market Share by Country
    11.2 Saudi Arabia
    11.3 United Arab Emirates
    11.4 Nigeria
    11.5 South Africa
    11.6 Others
    12 Patent Analysis
    12.1 Analysis by Type of Patent
    12.2 Analysis by Publication year
    12.3 Analysis by Issuing Authority
    12.4 Analysis by Patent Age
    12.5 Analysis by CPC Analysis
    12.6 Analysis by Patent Valuation
    12.7 Analysis by Key Players
    13 Grants Analysis
    13.1 Analysis by year
    13.2 Analysis by Amount Awarded
    13.3 Analysis by Issuing Authority
    13.4 Analysis by Grant Application
    13.5 Analysis by Funding Institute
    13.6 Analysis by NIH Departments
    13.7 Analysis by Recipient Organization
    14 Funding & Investment Analysis
    14.1 Analysis by Funding Instances
    14.2 Analysis by Type of Funding
    14.3 Analysis by Funding Amount
    14.4 Analysis by Leading Players
    14.5 Analysis by Leading Investors
    14.6 Analysis by Geography
    15 Partnership and Collaborations Analysis
    15.1 Analysis by Partnership Instances
    15.2 Analysis by Type of Partnership
    15.3 Analysis by Leading Players
    15.4 Analysis by Geography
    16 Supplier Landscape
    16.1 ABBOTT
    16.1.1 Financial Analysis
    16.1.2 Product Portfolio
    16.1.3 Demographic Reach and Achievements
    16.1.4 Mergers and Acquisition
    16.1.5 Certifications
    16.2 THERMO FISHER SCIENTIFIC
    16.2.1 Financial Analysis
    16.2.2 Product Portfolio
    16.2.3 Demographic Reach and Achievements
    16.2.4 Mergers and Acquisition
    16.2.5 Certifications
    16.3 F. HOFFMANN-LA ROCHE
    16.3.1 Financial Analysis
    16.3.2 Product Portfolio
    16.3.3 Demographic Reach and Achievements
    16.3.4 Mergers and Acquisition
    16.3.5 Certifications
    16.4 SIEMENS HEALTHINEERS AG
    16.4.1 Financial Analysis
    16.4.2 Product Portfolio
    16.4.3 Demographic Reach and Achievements
    16.4.4 Mergers and Acquisition
    16.4.5 Certifications
    16.5 DANAHER CORPORATION
    16.5.1 Financial Analysis
    16.5.2 Product Portfolio
    16.5.3 Demographic Reach and Achievements
    16.5.4 Mergers and Acquisition
    16.5.5 Certifications
    16.6 BIO-RAD LABORATORIES
    16.6.1 Financial Analysis
    16.6.2 Product Portfolio
    16.6.3 Demographic Reach and Achievements
    16.6.4 Mergers and Acquisition
    16.6.5 Certifications
    16.7 BIOMÉRIEUX SA
    16.7.1 Financial Analysis
    16.7.2 Product Portfolio
    16.7.3 Demographic Reach and Achievements
    16.7.4 Mergers and Acquisition
    16.7.5 Certifications
    16.8 THERADIAG
    16.8.1 Financial Analysis
    16.8.2 Product Portfolio
    16.8.3 Demographic Reach and Achievements
    16.8.4 Mergers and Acquisition
    16.8.5 Certifications
    16.9 GRIFOLS S.A.
    16.9.1 Financial Analysis
    16.9.2 Product Portfolio
    16.9.3 Demographic Reach and Achievements
    16.9.4 Mergers and Acquisition
    16.9.5 Certifications
    16.10 EXAGEN INC.
    16.10.1 Financial Analysis
    16.10.2 Product Portfolio
    16.10.3 Demographic Reach and Achievements
    16.10.4 Mergers and Acquisition
    16.10.5 Certifications
    16.11 ARK DIAGNOSTICS, INC.
    16.11.1 Financial Analysis
    16.11.2 Product Portfolio
    16.11.3 Demographic Reach and Achievements
    16.11.4 Mergers and Acquisition
    16.11.5 Certifications
    16.12 R-BIOPHARM A
    16.12.1 Financial Analysis
    16.12.2 Product Portfolio
    16.12.3 Demographic Reach and Achievements
    16.12.4 Mergers and Acquisition
    16.12.5 Certifications
    16.13 APDIA GROUP
    16.13.1 Financial Analysis
    16.13.2 Product Portfolio
    16.13.3 Demographic Reach and Achievements
    16.13.4 Mergers and Acquisition
    16.13.5 Certifications
    16.14 BIOTEZ BERLIN BUCH GMBH
    16.14.1 Financial Analysis
    16.14.2 Product Portfolio
    16.14.3 Demographic Reach and Achievements
    16.14.4 Mergers and Acquisition
    16.14.5 Certifications
    16.15 EAGLE BIOSCIENCES, INC.
    16.15.1 Financial Analysis
    16.15.2 Product Portfolio
    16.15.3 Demographic Reach and Achievements
    16.15.4 Mergers and Acquisition
    16.15.5 Certifications
    17 Global Therapeutic Drug Monitoring Market - Distribution Model (Additional Insight)
    17.1 Overview
    17.2 Potential Distributors
    17.3 Key Parameters for Distribution Partner Assessment
    18 Key Opinion Leaders (KOL) Insights (Additional Insight)
    19 Company Competitiveness Analysis (Additional Insight)
    19.1 Very Small Companies
    19.2 Small Companies
    19.3 Mid-Sized Companies
    19.4 Large Companies
    19.5 Very Large Companies
    20 Payment Methods (Additional Insight)
    20.1 Government Funded
    20.2 Private Insurance
    20.3 Out-of-Pocket

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us